A recent study demonstrated that THBS2 secreted by cancer-associated fibroblasts (CAFs) promotes CRC progression by binding to CD47 on tumour cells and activating the MAPK/ERK5 signalling cascade (Liu et al., 2025). The gene discussed is CD47; the disease is cancer.